- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 35.11M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 34.67M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 32.18M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 31.7M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $3.07M |
| Capex | Q3 2025 · Sep 30, 2024 | $4.82M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $17.64M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | $10.9M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $348.95M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $341.74M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $10.1M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $5.4M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $41.46M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $32.74M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$230.37M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$216.57M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $93.23M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $107.89M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $559M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $597.4M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $99.22M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $84.15M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $355.3M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $403.4M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.29 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.88 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.18 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.29 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.88 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $24.66M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $94.29M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $46.16M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $119.77M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$4.86M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$5.81M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$12.12M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$24.16M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $3.57M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $28.07M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$6.61M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$1.7M |
| Revenue | Q3 2025 · Sep 30, 2025 | $78.82M |
| Revenue | Q3 2025 · Sep 30, 2025 | $231.92M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $80.53M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $237.13M |